Latest News about NVS
Recent news which mentions NVS
AstraZeneca, Sanofi And Other Pharma Giants Pursue Chinese Deals Despite Rising US-China Strife
July 23, 2024
From Benzinga
Tickers
NVS
From Motley Fool
From Benzinga
Novartis' Q2 Earnings: Revenue And EPS Beat, Raises 2024 Profit Forecast On Strong Demand For Key Drugs
July 18, 2024
From Benzinga
From Benzinga
Alnylam Stock Is a Blockbuster Biopharma In the Making
July 18, 2024
From InvestorPlace
Tickers
NVS
From InvestorPlace
2 Magnificent Stocks to Buy With $500
July 18, 2024
From Motley Fool
From Benzinga
From InvestorPlace
3 Spinoff Stocks You Should Buy Now: July 2024
July 15, 2024
From InvestorPlace
From Benzinga
From InvestorPlace
3 Healthcare Stocks Injecting AI for Big Gains
July 13, 2024
From InvestorPlace
The 3 Most Undervalued Pharma Stocks to Buy in July 2024
July 12, 2024
From InvestorPlace
Ozempic Maker Novo Nordisk Reprimanded by UK Regulators for Payment Disclosure Failures
July 05, 2024
From Benzinga
Upcoming Stock Spinoffs: Should You Pounce or Pass?
July 04, 2024
From InvestorPlace
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Tags
Stocks to Buy
NYSE:BMY,NASDAQ:NBIX,NASDAQ:AMGN,NASDAQ:GILD,NYSE:NVS,NASDAQ:BLUE,NASDAQ:RARE
AMGN
From InvestorPlace
3 Crazy Good Stocks to Buy With $500 Right Now
June 12, 2024
From InvestorPlace
Italy Probes European Pharma Giants Novartis, Roche Over Eye Drug Competition Allegations
June 06, 2024
From Benzinga
From InvestorPlace
From Benzinga
Novartis' Oral Drug For Chronic Skin Disease Candidate Shows Efficacy, Long-term Safety
May 31, 2024
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
